Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-23-011282
Date:2023-02-16
Issuer: ATYR PHARMA INC (LIFE)
Original Submission Date:

Reporting Person:

SHUKLA SANJAY
3545 JOHN HOPKINS COURT, SUITE #250
SAN DIEGO, CA 92121

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
EMPLOYEE STOCK OPTION (RIGHT TO BUY) 2.195 2023-02-16 deemed execution date A 336,096 (a) 2033-02-16 common stock 336,096 $2.20 336,096 direct
Footnotes
IDfootnote
f1 the shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning march 16, 2023, such that this option will be fully exercisable on february 16, 2027. this option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.
WhaleWisdom Logo

Elevate your investments